Cargando…

Treatment Outcomes of Clopidogrel in Patients With ACS and Diabetes Undergoing PCI-Analysis of Beijing Municipal Medical Insurance Database

BACKGROUND AND AIMS: Several clinical trials have proved the efficacy of clopidogrel treatment for patients with percutaneous coronary intervention. There are few large-scale studies to identify the mortality associated with different durations of treatment of clopidogrel in patients with diabetes a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Weihao, Wang, Xiaoxia, Zhang, Lina, Zhang, Jie, Man, Fuli, Pan, Qi, Guo, Lixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362599/ https://www.ncbi.nlm.nih.gov/pubmed/34394007 http://dx.doi.org/10.3389/fendo.2021.713849

Ejemplares similares

Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study
por: Qiao, Jingtao, et al.
Publicado: (2022)

Ticagrelor versus Clopidogrel in Patients with Severe Renal Insufficiency Undergoing PCI for Acute Coronary Syndrome
por: Chen, Yunxian, et al.
Publicado: (2022)

The effect of ticagrelor on coronary microvascular function after PCI in patients with ACS compared to clopidogrel: A systematic review and meta-analysis
por: Qiu, Xiaohan, et al.
Publicado: (2023)

Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China
por: Gong, Xuhe, et al.
Publicado: (2022)

Body Mass Index Has a Nonlinear Association With Postoperative 30-Day Mortality in Patients Undergoing Craniotomy for Tumors in Men: An Analysis of Data From the ACS NSQIP Database
por: Liu, Yufei, et al.
Publicado: (2022)

Variants of PEAR1 Are Associated With Outcome in Patients With ACS and Stable CAD Undergoing PCI
por: Stimpfle, Fabian, et al.
Publicado: (2018)

Sex-related differences in clinical outcomes and predictive factors in the very elderly patients with ACS undergoing PCI
por: Wang, Jia-li, et al.
Publicado: (2022)

Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis
por: Serbin, Michael A., et al.
Publicado: (2016)

Efficacy and Safety Profile of Ticagrelor Versus Clopidogrel in Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome (ACS): A Systematic Review and Meta-Analysis
por: Maqbool, Shahzaib, et al.
Publicado: (2023)

Safety and Efficacy Evaluation of Antithrombotic Therapy with Rivaroxaban and Clopidogrel After PCI in Chinese Patients
por: Bai, Long, et al.
Publicado: (2022)

Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI
por: Guo, Yong-zhe, et al.
Publicado: (2021)

The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals
por: Pan, Qi, et al.
Publicado: (2022)

Prolonged dual antiplatelet therapy for Chinese ACS patients undergoing emergency PCI with drug-eluting stents: Benefits and risks
por: Zhang, Yong, et al.
Publicado: (2023)

Effects of SGLT-2 Inhibitors on Vascular Endothelial Function and Arterial Stiffness in Subjects With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Wei, Ran, et al.
Publicado: (2022)

Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry
por: Völz, Sebastian, et al.
Publicado: (2020)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
por: Wang, Zhe, et al.
Publicado: (2020)

Usefulness of FT3 to FT4 Ratio to Predict Mortality in Euthyroid Patients With Prior Cardiovascular Events Undergoing PCI: Five-Year Findings From a Large Single-Center Cohort Study
por: Yuan, Deshan, et al.
Publicado: (2021)

Personalized Antiplatelet Therapy Based on CYP2C19 Genotypes in Chinese ACS Patients Undergoing PCI: A Randomized Controlled Trial
por: Shi, Xiujin, et al.
Publicado: (2021)

Combination of TyG Index and GRACE Risk Score as Long-Term Prognostic Marker in Patients with ACS Complicated with T2DM Undergoing PCI
por: Qin, Zhen, et al.
Publicado: (2022)

Hypoglycemia as a potential risk for patients taking clopidogrel: A systematic review and meta-analysis
por: Chen, Shi, et al.
Publicado: (2023)

An analysis of patients receiving emergency CAG without PCI and the value of GRACE score in predicting PCI possibilities in NSTE-ACS patients
por: Zhou, Bo-Da, et al.
Publicado: (2015)

PSUN128 Insurance Database Analysis of Healthcare Utilization by Women with PCOS
por: Lawrence, Rebecca, et al.
Publicado: (2022)

Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI
por: Yamamoto, Ko, et al.
Publicado: (2023)

How does diabetic peripheral neuropathy impact patients' burden of illness and the economy? A retrospective study in Beijing, China
por: Pan, Qi, et al.
Publicado: (2023)

Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI)
por: Chen, Shuxia, et al.
Publicado: (2017)

Clinical characteristics associated with high on-treatment platelet reactivity of patients undergoing PCI after a 300 mg loading dose of clopidogrel, measured by thrombelastography
por: Hou, Xu-Min, et al.
Publicado: (2013)

The Impact of Kinase Insert Domain (KDR) Gene Polymorphism rs2305948 on Clopidogrel Resistance in Iraqi Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)
por: Ahmed, Ali A., et al.
Publicado: (2020)

Healthcare, Insurance, and Medical Expenditure of the Floating Population in Beijing, China
por: Ma, Chenjin, et al.
Publicado: (2020)

Clinical Analysis of Preoperative Anti-thyroglobulin Antibody in Papillary Thyroid Cancer Between 2011 and 2015 in Beijing, China: A Retrospective Study
por: Jia, Xiaomeng, et al.
Publicado: (2020)

Iron Deficiency, a Risk Factor of Thyroid Disorders in Reproductive-Age and Pregnant Women: A Systematic Review and Meta-Analysis
por: Luo, Jingyi, et al.
Publicado: (2021)

Improvement of long-term clinical outcomes by successful PCI in the very elderly women with ACS
por: Wang, Jia-li, et al.
Publicado: (2021)

Prevalence and Impact of Arrhythmia on Outcomes in Restrictive Cardiomyopathy—A Report from the Beijing Municipal Health Commission Information Center (BMHCIC) Database
por: Wang, Haiyan, et al.
Publicado: (2023)

Effects of different CYP2C19 genotypes on prognosis of patients complicated with atrial fibrillation taking clopidogrel after PCI
por: Zhang, Qifeng, et al.
Publicado: (2018)

A self-controlled, cross-over study of intensive insulin treatment with needle-based injection versus needle-free injection in hospitalized patients with type 2 diabetes
por: Wu, Quanying, et al.
Publicado: (2023)

De-Escalation Therapy After PCI in ACS Patients With Chronic Kidney Disease
por: Natsuaki, Masahiro, et al.
Publicado: (2023)

Feasibility analysis of incorporating infertility into medical insurance in China
por: Wang, Lin, et al.
Publicado: (2022)

Drug-Coated Balloon Treatment for ACS Induced by Myocardial Bridging: An Intravascular Ultrasound-Guided PCI
por: Shen, Linghong, et al.
Publicado: (2020)

Metformin treatment and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in Beijing, China
por: Yang, Ruotong, et al.
Publicado: (2023)

Letter to the Editor: How Should We Treat High-risk Patients in the Chronic Phase Following PCI: Clopidogrel or Prolonged DAPT?
por: Wang, Hao-Yu, et al.
Publicado: (2021)

Higher Neutrophil to Lymphocyte Ratio at Admission is Association with Post-PCI Depressive Symptoms in Patients with ACS
por: Li, Cexing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hqtgjrd7tq65adqq6rgdj93g5v